Regulation - North America, Mekinist


Current filters:

North AmericaMekinist

Popular Filters

GlaxoSmithKline files sNDAs for combination melanoma drugs


UK pharma giant GlaxoSmithKline (LSE: GSK) said today (July 9) that it has submitted supplemental New…

BiotechnologyGlaxoSmithKlineMekinistNorth AmericaOncologyPharmaceuticalRegulationTafinlar

FDA approves two GSK melanoma drugs and bioMerieux companion diagnostic


The US Food and Drug Administration yesterday (May 29) approved two new oral drugs from UK pharma giant…

BioMerieuxdabrafenibGlaxoSmithKlineMekinistNorth AmericaOncologyPharmaceuticalRegulationTafinlartrametinib

Back to top